Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2019 17:00 ET | Source: Dynavax Technologies Corporation

Dynavax Announces First Patient Enrolled in Study of HEPLISAV-B® [Hepatitis B Vaccine, Recombinant (Adjuvanted)] in Adults With End-Stage Renal Disease

BERKELEY, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering, developing and...
May 02, 2019 13:14 ET | Source: Association of Gaming Equipment Manufacturers

Association of Gaming Equipment Manufacturers (AGEM) Hails Passage of Assembly Bill 221 That Expands Nevada’s Gaming Technology Workforce

CARSON CITY, Nev., May 02, 2019 (GLOBE NEWSWIRE) -- The Association of Gaming Equipment Manufacturers (AGEM) announced today the passage by the Nevada Legislature of Assembly Bill 221 that expands...
May 02, 2019 11:41 ET | Source: Reports And Data

Anesthesia CO2 Absorbent Market To Reach USD 106.5 Million By 2026 | Reports And Data

The rising incidences of medical conditions which require surgeries are estimated to drive the market demand. Market Size – USD 56.9 million in 2018, Market Growth - CAGR of 8.1%, Market Trends –...
May 02, 2019 09:12 ET | Source: Family Features

How Children Can Receive Free or Low-Cost Preventive Care

MISSION, Kan., May 02, 2019 (GLOBE NEWSWIRE) -- (Family Features) Children are among the most vulnerable populations when it comes to measles and other highly contagious diseases. Giving babies the...
May 02, 2019 01:00 ET | Source: VALNEVA

Ad hoc: Valneva gibt starke Q1 2019 Betriebsergebnisse bekannt und bringt führende F&E-Programme in Richtung wichtiger Meilensteine voran

Valneva gibt starke Q1 2019 Betriebsergebnisse bekannt und bringt führende F&E-Programme in Richtung wichtiger Meilensteine voran Wiederholtes deutliches Umsatzwachstum bei IXIARO®; die...
May 02, 2019 01:00 ET | Source: VALNEVA

VALNEVA : très bons résultats opérationnels au T1 2019, avancée des programmes clés vers d'importants jalons R&D

Valneva : très bons résultats opérationnels au T1 2019, avancée des programmes clés vers d'importants jalons R&D Croissance significative et répétée des ventes d'IXIARO®; Avancée des...
May 02, 2019 01:00 ET | Source: VALNEVA

VALNEVA Reports Strong Q1 2019 Operating Results and Advances Key R&D Programs towards Major Milestones

Valneva Reports Strong Q1 2019 Operating Results and Advances Key R&D Programstowards Major Milestones Repeated significant growth in IXIARO® revenues; Lyme disease and chikungunya programs...
April 30, 2019 13:11 ET | Source: Research and Markets

The Global Skin Cancer Therapeutics Market to 2024 - Extensive R&D Pipelines & Raising Awareness Spur Growth

Dublin, April 30, 2019 (GLOBE NEWSWIRE) -- The "Skin Cancer Therapeutics Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's ...
April 29, 2019 12:08 ET | Source: Association of American Physicians and Surgeons

Lawsuit against NYC Vaccine Order Dismissed, States Association of American Physicians and Surgeons (AAPS)

TUCSON, Ariz., April 29, 2019 (GLOBE NEWSWIRE) -- Brooklyn Judge Lawrence Knipel has dismissed a lawsuit (C.F. v. NYC Health Commissioner) brought by five mothers against Mayor Bill de Blasio’s...
April 29, 2019 04:15 ET | Source: Research and Markets

Global $1.5+ Bn Remote Patient Monitoring Devices Market 2018-2019 & 2027

Dublin, April 29, 2019 (GLOBE NEWSWIRE) -- The "Remote Patient Monitoring Devices Market to 2027 - Global Analysis and Forecasts By Product, Application End User and Geography" report has been...